3096 results about "Boronic acid" patented technology

The present invention provides a sensor surface comprising: a substrate coated with a free electron metal; and a matrix layer disposed on the free electron metal, wherein the matrix layer comprises an organic compound having a boronic acid complexing moiety. The matrix is preferably a self-assembled monolayer (SAM), a mixed self-assembled monolayer (mSAM), or combinations thereof.

Disclosed herein are antimicrobial compounds compositions, pharmaceutical compositions, the use and preparation thereof. Some embodiments relate to 1 cyclic boronic acid ester derivatives and their use as therapeutic agents.

The invention discloses a multifunctional concrete structure endurance protective agent as well as the preparation and application method thereof. The protective agent provided by the invention contains the following ingredients of: an organic / inorganic composite fluorosilicone-acrylate copolymer, lithium silicate, sodium silicate, lithium molybdate, sodium tetraborate, sal glauberi, 1,2-aminoazophenylene, nanometer titanium dioxide, anhydrous ethanol and water. The protective agent can penetrate inside concrete, wherein a densification ingredient can minimize internal holes and cracks to raise the compactness of concrete, and a rust-resistant ingredient can penetrate into concrete and be adsorbed on the surface of steel bar so as to passivate and protect the steel bar; the low-surface energy silicon fluoride ingredient can be solidified to form a cured film on the surface of concrete so as to endow the protective agent with the hydrophobic performance; a nanometer ingredient can endow the cured film layer with properties of resisting ultraviolet and ageing and improving the organic polymer performance as well as the self-cleaning performance. In addition, hydroxy generated from the hydrolysis of siloxane group can perform a condensation reaction with hydroxy on the surface of concrete to produce chemical bond, so as to raise the anchoring strength between the film and concrete and improve the interface combination. The protective agent provided by the invention can be widely applied in various concrete structure engineering protections to raise the service life of concrete.

Benzimidazole, indole and benzolactam boronic acid compounds, analogs thereof, and pharmaceutical formulations are described, along with methods of use thereof for inhibiting inflammatory cytokines such as tumor necrosis factor alpha (TNF-α) in a subject in need thereof.

The present invention concerns an improved optical method and optical sensing device for determining the levels of polyhydroxyl-substituted organic molecules in vitro and / or in vivo in aqueous media. The range of detection is between about 400 and 800 nm. In particular, a sensory devise is implemented in a mammal to determine sugar levels. Specifically, a dye is combined with a conjugated nitrogen-containing heterocyclic aromatic boronic acid-substituted bis-onium compound in the presence of a sugar, such as fructose or glucose. The viologens are preferred as the aromatic conjugated nitrogen-containing boronic acid substituted compounds. The method is useful to determine sugar levels in a human being.

Disclosed herein are antimicrobial compounds compositions, pharmaceutical compositions, the use and preparation thereof. Some embodiments relate to boronic acid derivatives and their use as therapeutic agents.

A process for forming an unsymmetric anthracene compound comprises a first step of forming a 9-perfluoroalkylsulfonate derivative of anthrone by reacting the anthrone with a perfluoroalkyl sulfonating agent, followed by a second step of contacting the reaction product with an aryl or heteroaryl boronic acid, ester or anhydride, and a palladium catalyst for a period of time sufficient to form an unsymmetric anthracene compound having at least one 9-position aromatic substituent.

The present invention is directed to pyrrolidinylaminoacetyl pyrrolidine boronic acid compounds that display selective, potent dipeptidyl peptidase IV inhibitory activity. These compounds are useful for the treatment of disorders that can be regulated or normalized via inhibition of DPP-IV including those characterized by impaired glycemic control such as Diabetes Mellitus and related conditions. The compounds can be administered alone or with another medicament that displays pharmacological activity for treatment of these and other diseases.

The invention relates to the formulation of pharmaceutical compounds. More particularly, the invention provides stable, pharmaceutically acceptable compositions prepared from boronic acid compounds and methods for preparing the compositions. The invention also provides novel boronate ester compounds. The invention further provides boronic acid anhydride compounds useful in the methods of the invention.

Quaternary nitrogen heterocyclic boronic acid-containing compounds are described, which are sensitive to glucose and fructose, as well as a variety of other physiologically important analytes, such as aqueous chloride and iodide, and a method of using the compounds. Also disclosed is a contact lens doped with the quaternary nitrogen heterocyclic boronic acid-containing compound, and a method of using the doped contact lens to measure the concentration of analyte in tears under physiological conditions.